GTR 111342865

Bids Are Invited For Price Registration For The Acquisition Of Medicines For Human Use (Basic, Specialized And Special Control), In Installments, Aiming At Maintaining The Stock And Pharmaceutical Assistance Of The Public Health Network Of Tacaimbó/Pe, According To Specifications, Quantities And Conditions Established In The Notice And Its Annexes

ICB — International Competitive Bid Closed South America
Tender Information
GTR Reference
111342865
Tendering Authority
Subscribe to view
Tender No
8/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For Price Registration For The Acquisition Of Medicines For Human Use (Basic, Specialized And Special Control), In Installments, Aiming At Maintaining The Stock And Pharmaceutical Assistance Of The Public Health Network Of Tacaimbó/Pe, According To Specifications, Quantities And Conditions Established In The Notice And Its Annexes
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
17-04-2026 Closed
Work Detail
Acetylcysteine, Concentration:40 Mg/Ml, Pharmaceutical Form:Syrup, Dosage:20 Mg/Ml, Indication:Syrup, Acetylsalicylic Acid, Dosage:100 Mg, Ascorbic Acid, Concentration:200 Mg/Ml, Pharmaceutical Form:Injectable Solution, Concentration:500 Mg, Form Pharmaceutical:Extended Release, 01/04/2026 - 16:55:23, Dosage:200 Mg/Ml, Type Of Use:Oral Solution, Folic Acid, Dosage:5 Mg, Tranexamic Acid, Dosage: 50 Mg/Ml, Pharmaceutical Form: Injectable Solution, Valproic Acid, Dosage:500 Mg, Dosage:50 Mg/Ml, Albendazole, Dosage:400 Mg, Dosage:40 Mg/Ml, Use:Oral Suspension, Algestone Acetophenide, Active Ingredient:Associated With Estradiol Enanthate, Dosage:150 Mg + 10 Mg/Ml, Alprazolam, Dosage:0, 25 Mg, Dosage:1 Mg, Dosage: 2 Mg, Ambroxol, Composition: Hydrochloride Salt, Concentration: 3 Mg/Ml, Concentration: 6 Mg/Ml, Amitriptyline Hydrochloride, Dosage: 25 Mg, Dosage: 75 Mg, Amoxicillin, Concentration: 500Mg, Concentration: 50Mg/Ml, Presentation: Powder For Oral Suspension, Active Ingredient:Associated With Potassium Clavulanate, Concentration:25 Mg/Ml + 6.25 Mg/Ml, Pharmaceutical Form:Oral Suspension, Concentration:500Mg + 125Mg, Concentration:50 Mg/Ml + 12.5 Mg/Ml, Concentration:875Mg + 125Mg, Amlodipine Besylate, Dosage:10 Mg, Atenolol, Dosage:25 Mg, Dosage:50 Mg, Azithromycin, Presentation:Oral Suspension, Atropine Sulfate, Dosage: 0.50 Mg/Ml, Use: Injectable Solution, Benzylpenicillin, Presentation:Benzatine, Dosage:1,200,000Ui, Use:Injectable, Dosage:600,000Ui, Betamethasone, Presentation: Associated With Dexchlorpheniramine Maleate, 25Mg + 2Mg, Biperiden, Bisacodyl, Bromazepam, Dosage:3 Mg, Dosage:6 Mg, Bromopride, Dosage:4 Mg/Ml, Presentation: Drops, Bupivacaine Hydrochloride, Purity: 0.5%, Presentation: Injectable Solution, Bupropion Hydrochloride, Dosage: 150 Mg, Cannabidiol, Composition: Associated With Tetrahydrocannabinol (Thc), Concentration: 1 Mg/Ml + 20 Mg/Ml, Pharmaceutical Form: Oral Solution - Drops, Captopril, Concentration: 25 Mg, Carbamazepine, Dosage: 200 Mg, Lithium Carbonate, Dosage: 300 Mg, Dosage: 450 Mg, Carvedilol, Dosage: 12. 5 Mg, Dosage: 3. 125 Mg, Dosage: 6, Cephalexin, Concentration: 100 Mg/Ml, Form Pharmaceutical: Powder For Oral Suspension, Additional Description: 100 Ml Bottle, Ceftriaxone Sodium, Concentration: 1 G, Pharmaceutical Form: Powder For Injectable Solution, Concentration: 500 Mg, Pharmaceutical Form: Powder For Injectable Solution, Ketoconazole, Dosage: 20 Mg/G, Pharmaceutical Form: Cream Topical, Ketoprofen, Concentration: 150 Mg, Concentration: 50 Mg/Ml, Ciprofibrate, Dosage: 100 Mg, Ciprofloxacin Hydrochloride, Dosage: 2 Mg/Ml, Presentation: Injectable Solution, Citalopram, Dosage: 20 Mg, Clindamycin, Clonazepam, Dosage: 2, Presentation: Oral Solution - Drops, Clonidine Hydrochloride, Concentration: 0.15 Mg/Ml, Clopidogrel, Sodium Chloride, Concentration: 30 Mg/Ml, Pharmaceutical Form: Nasal Solution, Chlorhexidine Digluconate, Physical Aspect: Liquid, Concentration: In 20% Aqueous Solution, Chlorpromazine, Collagenase, Presentation: Associated With Chloramphenicol, Concentration: 0.6Ui + 1%, Use: Ointment, Dapagliflozin, Concentration: 10 Mg, Desloratadine, Desvenlafaxine, Composition: Succinate Salt, Concentration: 100 Mg, Pharmaceutical Form: Controlled Release, Concentration: 50 Mg, Dexamethasone, Concentration:2 Mg/Ml, 1%, Presentation:Cream, 1 Mg/Ml, Presentation:Elixir, Dosage:4 Mg, Dexchlorpheniramine Maleate, 4 Mg/Ml, Presentation:Oral Solution, Diazepam, Concentration:10 Mg/Ml, Dosage:5 Mg/Ml, Diclofenac, Presentation:Salt Potassium, Presentation:Sodium Salt, Dosage:25Mg/Ml, Use:Injectable Solution
Key Value
Tender Value
2,048,454 - BRL
Tender Documents
Global Tender Document
ad0c60af-04fb-4470-a0d4-cdd4dffd8d82.html
Attachments
Additional Details Available on Click
  • Tendering Authority
  • Publication Document (Tender Document / Tender Notice)
Disclaimer

We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.

Tell us about your Product / Services,

We will Find Tenders for you

TenderDetail
Loading tenders